Kuhlmann P - Search Results

1

Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma.

Tamukong PK, Kuhlmann P, You S, Su S, Wang Y, Yoon S, Gong J, Figlin RA, Janes JL, Freedland SJ, Halabi S, Small EJ, Rini BI, Kim HL. Tamukong PK, et al. Among authors: kuhlmann p. Urol Oncol. 2022 Nov;40(11):495.e1-495.e10. doi: 10.1016/j.urolonc.2022.07.010. Epub 2022 Aug 13. Urol Oncol. 2022. PMID: 35973929

2

Public interest in dietary supplements for prostate cancer prevention.

Patel DN, Kuhlmann P, Lin PH, Freedland SJ. Patel DN, et al. Among authors: kuhlmann p. Prostate Cancer Prostatic Dis. 2021 Mar;24(1):58-60. doi: 10.1038/s41391-020-0257-8. Epub 2020 Jul 19. Prostate Cancer Prostatic Dis. 2021. PMID: 32684622 Review. No abstract available.

3

Patient- and tumor-level risk factors for MRI-invisible prostate cancer.

Kuhlmann PK, Chen M, Luu M, Naser-Tavakolian A, Patel DN, Kim HL, Saouaf R, Daskivich TJ. Kuhlmann PK, et al. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):794-801. doi: 10.1038/s41391-021-00330-7. Epub 2021 Feb 10. Prostate Cancer Prostatic Dis. 2021. PMID: 33568751

4

Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial.

Kuhlmann PK, Fischer SC, Howard LE, Moreira DM, Andriole GL, Hopp ML, Roehrborn CG, Bliwise DL, Freedland SJ. Kuhlmann PK, et al. J Urol. 2021 Jun;205(6):1733-1739. doi: 10.1097/JU.0000000000001640. Epub 2021 Feb 19. J Urol. 2021. PMID: 33605791 Clinical Trial.

5

Correction: Public interest in dietary supplements for prostate cancer prevention.

Patel DN, Kuhlmann P, Lin PH, Freedland SJ. Patel DN, et al. Among authors: kuhlmann p. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):376. doi: 10.1038/s41391-021-00410-8. Prostate Cancer Prostatic Dis. 2022. PMID: 34145429 No abstract available.

6

Predictors of disparity between targeted and in-zone systematic cores during transrectal MR/US-fusion prostate biopsy.

Kuhlmann PK, Chen M, Luu M, Naser-Tavakolian A, Kim HL, Saouaf R, Daskivich TJ. Kuhlmann PK, et al. Urol Oncol. 2022 Apr;40(4):162.e1-162.e7. doi: 10.1016/j.urolonc.2021.12.016. Epub 2022 Jan 20. Urol Oncol. 2022. PMID: 35067431

7

A modeling study to estimate prostate cancer-specific mortality on active surveillance for men with favorable intermediate-risk prostate cancer: Results from the SEARCH cohort.

Kuhlmann PK, Oyekunle T, Klaassen Z, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ. Kuhlmann PK, et al. Cancer Med. 2023 May;12(9):10931-10938. doi: 10.1002/cam4.5805. Epub 2023 Apr 9. Cancer Med. 2023. PMID: 37031461 Free PMC article.

8

Potential miscommunication of risk in American College of Radiology Prostate Imaging and Data System (PIRADS) scores.

Dallmer JR, Spiegel B, Freedland SJ, Saouaf R, Kuhlmann P, Daskivich TJ. Dallmer JR, et al. Among authors: kuhlmann p. Prostate Cancer Prostatic Dis. 2024 Jan 3. doi: 10.1038/s41391-023-00781-0. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38172198 Review. No abstract available.

9

Risk Factors for Intraoperative Bladder Perforation at the Time of Midurethral Sling Placement.

Kuhlmann PK, Dallas K, Masterson J, Patel DN, Chen A, Castaneda P, Ackerman AL, Anger JT, Eilber KS. Kuhlmann PK, et al. Urology. 2021 Feb;148:100-105. doi: 10.1016/j.urology.2020.11.023. Epub 2020 Nov 21. Urology. 2021. PMID: 33227306

10

Economic evaluation of elective cesarean versus vaginal delivery on cost of future pelvic floor disorders in the United States.

Kuhlmann PK, Patel DN, Chen A, Houman J, Weinberger J, Wood Thum LN, Anger JT, Eilber KS. Kuhlmann PK, et al. Neurourol Urodyn. 2021 Jan;40(1):451-460. doi: 10.1002/nau.24582. Epub 2020 Nov 24. Neurourol Urodyn. 2021. PMID: 33232551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page